Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden · Delayed Price · Currency is SEK 1.920
+0.060 (3.23%)
Mar 4, 2026, 5:29 PM CET
37.34% (1Y)
| Market Cap | 196.26M +84.4% |
| Revenue (ttm) | 167.17M +152.7% |
| Net Income | 91.74M |
| EPS | 0.98 |
| Shares Out | 105.52M |
| PE Ratio | 1.90 |
| Forward PE | 6.20 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 631,017 |
| Average Volume | 1,232,278 |
| Open | 1.825 |
| Previous Close | 1.860 |
| Day's Range | 1.825 - 1.920 |
| 52-Week Range | 0.360 - 2.350 |
| Beta | -0.72 |
| RSI | 47.14 |
| Earnings Date | Feb 12, 2026 |